Industry Ignited Podcast

What Happens When Pharma Measures Performance Like the Olympics? Tim Mikhelashvili, Amedea Pharma | Ep. 54

Leeanne Aguilar, Ph.D. Season 1 Episode 54

In this Industry Ignited episode, Dr. Leeanne Aguilar sits down with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, to explore how life sciences can achieve elite performance by borrowing principles from Olympic sports and data science. Drawing on more than 20 years across pharma, biotech, and medical affairs, Tim shares how early exposure to drug recalls and poor manufacturing conditions shaped his mission to raise healthcare quality standards, why traditional metrics fail to drive real accountability, and how organizations can connect purpose, progress, and reward through transparent performance systems. Healthcare organizations don’t need more pressure—they need better accountability models that measure both results and behaviors, empowering teams to operate like championship athletes while improving patient outcomes. From launching the ANCORA platform to hosting the Medical Innovation Olympics, Tim offers a compelling blueprint for turning accountability into motivation and scaling excellence across the life sciences industry.